See also this year's filing and all EDGAR filings for this company.
PDF Report 0001322505_2013_Albireo_Pharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001322505, Albireo Pharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 39,536,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 46,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,552,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 2,780,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 7,338,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,816,000 |
| 9 | ResearchAndDevelopmentExpense | 12,571,000 |
| 10 | remainder_Expenses | 8,000 |
| 11 | remainder_Revenues | 80,000 |
| 12 | remainder_NetIncome | -2,137,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 41,134,000 |
| 1 | Liabilities | 10,118,000 |
| 2 | Expenses | 19,395,000 |
| 3 | Revenues | 80,000 |
| 4 | StockholdersEquity | 31,016,000 |
| 5 | NetIncome | -21,452,000 |
| 6 | ComprehensiveNetIncome | -21,452,000 |
| 7 | BaseVar | 36,432,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.80 |
| 9 | EconomicCapitalRatio | 2.89 |